ロード中...

Safe administration of bevacizumab combination chemotherapy for the patients with recurrent cervical cancer after pelvic radiotherapy: Two case reports

In Japan, bevacizumab has not been proven either effective or safe for the treatment of recurrent cervical cancer. The present study reported two cases in which bevacizumab combination chemotherapy was safely administered for recurrent cervical cancer following pelvic radiotherapy. Case 1 was a 62-y...

詳細記述

保存先:
書誌詳細
出版年:Mol Clin Oncol
主要な著者: Shoji, Tadahiro, Takeshita, Ryosuke, Mukaida, Rika, Takatori, Eriko, Nagasawa, Takayuki, Omi, Hideo, Sugiyama, Toru
フォーマット: Artigo
言語:Inglês
出版事項: D.A. Spandidos 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6083409/
https://ncbi.nlm.nih.gov/pubmed/30101016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1642
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!